# Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.

> **NCT02983890** · PHASE1 · COMPLETED · sponsor: **Per Damkier** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dicloxacillin
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02983890
- **Lead sponsor:** Per Damkier
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-06
- **Primary completion:** 2017-04-05
- **Final completion:** 2017-10-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02983890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02983890, "Dicloxacillin: Clinical Relevance of Drug-drug Interactions by Induction of Drug Metabolism.". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02983890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*